Thank you for your interest in the whitepaper:
High Yield Considerations for Clinical Development in Rare & Genetic Diseases of the Kidney
Learn More About Medpace’s
Nephrology & Renal Disease Capabilities
Medpace has global experience conducting trials for a variety of kidney-related diseases from early through late phase. Our scientifically-driven approach to clinical development provides you the advantage of early and ongoing insight and guidance from therapeutic experts throughout trial design and execution.
You benefit from:
- In-house board-certified nephrologists with 40+ years of experience in clinical drug development, responsible for leading several drugs from early phase development through product launch
- Extensive global clinical trial experience in numerous nephrology indications
- Dedicated nephrology team with a thorough understanding of complex metabolic conditions that cause Chronic Kidney Disease (CKD), as well as the medical complications experienced by CKD and end-stage renal disease (ESRD) patients
- Well-established international relationships with experienced sites, networks, and KOLs specializing in nephrology
- A fully integrated solution with our in-house imaging core lab and global central lab to maximize efficiency
Learn more about our capabilities or contact us to connect with our internal experts.
You may also be interested in the article:
Chronic Kidney Disease: Diagnostics, Biomarkers and Strategies for More Representative Trials